Please assess the completion status of the following clinical trial:

Trial Title: Preoperative Cisplatin in Early Stage Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* All tumors must be ER-, PR- and HER-2 negative.~* Age \> 18 years~* ECOG performance status of less than or equal to 1~* Absolute neutrophil count (ANC) \> 1,500/mm3~* Hemoglobin \> 9mm/dl~* Platelets \> 100,000/mm3~* Creatinine \< 1.5mg/dl~* Glucose \< 200mg/dl~* Bilirubin \< 1.5 x upper limit of normal (ULN)~* SGOT \< 3.0 x ULN~Exclusion Criteria:~* Prior chemotherapy treatment~* Pregnant or breast-feeding women~* History of serious illness, medical or psychiatric condition requiring medical management~* Uncontrolled infection~* Renal dysfunction~* Active or severe cardiovascular or pulmonary disease~* Peripheral neuropathy of any etiology that exceeds grade 1~* Prior history of malignancy~* Uncontrolled diabetes

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention single arm (Type: EXPERIMENTAL): Cisplatin 75mg/m2 q21 days x 4 pre-surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).